HDL and arteriosclerosis: beyond reverse cholesterol transport.
about
Apolipoprotein A-IV inhibits experimental colitisApolipoprotein A-I activates cellular cAMP signaling through the ABCA1 transporterEffects of statins on high-density lipoproteins: a potential contribution to cardiovascular benefitLow High-Density Lipoprotein and Risk of Myocardial InfarctionHDL in sepsis - risk factor and therapeutic approachCholesterol: the good, the bad, and the ugly - therapeutic targets for the treatment of dyslipidemiaHigh-Density Lipoproteins: Nature's Multifunctional NanoparticlesParticulate matter and atherosclerosis: role of particle size, composition and oxidative stressAssessment of endothelial dysfunction in childhood obesity and clinical use.Surrogate markers for atherosclerosis in overweight subjects with atherogenic dyslipidemia: the GEMS project.Serum zinc and magnesium concentrations in type 2 diabetes mellitus with periodontitisUsing advanced intercross lines for high-resolution mapping of HDL cholesterol quantitative trait loci.Current status and future directions in lipid management: emphasizing low-density lipoproteins, high-density lipoproteins, and triglycerides as targets for therapy.Cholesterol binding, efflux, and a PDZ-interacting domain of scavenger receptor-BI mediate HDL-initiated signaling.Shorter GT repeat polymorphism in the heme oxygenase-1 gene promoter has protective effect on ischemic stroke in dyslipidemia patients.Increased serum triglyceride clearance and elevated high-density lipoprotein 2 and 3 cholesterol during treatment of primary hypertriglyceridemia with bezafibrate.Role of the adaptor protein PDZK1 in controlling the HDL receptor SR-BILow HDL levels in sepsis versus trauma patients in intensive care unit.Atherogenic dyslipidemia and combination pharmacotherapy in diabetes: recent clinical trials.The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis?ATP Synthase β-Chain Overexpression in SR-BI Knockout Mice Increases HDL Uptake and Reduces Plasma HDL LevelLevels of high-density lipoprotein cholesterol (HDL-C) among children with steady-state sickle cell disease.The rationality of the hypolipidemic effect of alismatis rhizoma decoction, a classical chinese medicine formula in high-fat diet-induced hyperlipidemic mice.Markers of Systemic Inflammation and Apo-AI Containing HDL Subpopulations in Women with and without DiabetesVitamin C may have similar beneficial effects to Gemfibrozil on serum high-density lipoprotein-cholesterol in type 2 diabetic patientsEffect of Erythrina variegata seed extract on hyperlipidemia elicited by high-fat diet in wistar ratsThe role of high-density lipoproteins in reducing the risk of vascular diseases, neurogenerative disorders, and cancer.Distinct HDL subclasses present similar intrinsic susceptibility to oxidation by HOCl.Weight loss is not mandatory for exercise-induced effects on health indices in females with metabolic syndromeLow serum high density lipoprotein cholesterol concentration is an independent predictor for enhanced inflammation and endothelial activation.Acrolein modification impairs key functional features of rat apolipoprotein E: identification of modified sites by mass spectrometry.High density lipoprotein stimulated migration of macrophages depends on the scavenger receptor class B, type I, PDZK1 and Akt1 and is blocked by sphingosine 1 phosphate receptor antagonists.High-density lipoprotein cholesterol in diabetes: is higher always better?Alterations in high-density lipoprotein metabolism and reverse cholesterol transport in insulin resistance and type 2 diabetes mellitus: role of lipolytic enzymes, lecithin:cholesterol acyltransferase and lipid transfer proteins.HDL revisited: new opportunities for managing dyslipoproteinaemia and cardiovascular disease.High density lipoprotein mediated lipid efflux from retinal pigment epithelial cells in culture.Recent advances in the secondary prevention of coronary heart disease.Effect of polysaccharide from Bacillus subtilis sp. on cardiovascular diseases and atherogenic indices in diabetic rats.HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3.The membrane lipid phosphatidylcholine is an unexpected source of triacylglycerol in the liver
P2860
Q24299366-47D8040E-D613-4999-BF94-41BBE42045A8Q24303830-3F2D9925-C931-4AA9-A7D8-171EA00B34C4Q24650533-47092299-21CC-46E2-BA36-863E7BC88E7EQ26773899-5E7EC01E-FC4C-46FF-825A-4CDC12142356Q26777964-E260D4CD-7D16-4C58-9484-706A1442E379Q27013494-747D4105-5C6F-4186-97DB-A15D5CE87317Q28077290-8F151CC1-D92C-4B07-A1B5-C98924EDAA48Q28391543-55593D58-5F6C-4CB7-AC6C-BC98891E17E8Q30430798-69E2A2EC-1C02-4851-8ED3-C75985DFA2B7Q33326943-ED430653-8145-4DFF-A927-67F0C36EE865Q33663790-43BD7CCA-BA32-4F6B-B49E-26AB1A400F26Q33680644-69627170-A087-424F-BA07-D816B63861CDQ33715404-131EBB7C-7EEF-4C78-AEA7-DF13F80BC337Q33723587-4D0F0353-4633-4A41-9A42-FEB743449122Q33736987-F78C6AD0-D851-4E67-BC71-3118BA7EE07AQ33739088-B5C79BF3-BD65-47F9-BE5C-AE53A72473A6Q33767978-98D5DBFC-541E-434F-BDE1-A6F515375090Q33770014-4EF4D30E-5692-4534-901E-F0A4A7C76991Q33776194-2AE93D4E-30C5-4AE1-8D9A-BAD76EA12EE9Q33993233-B7DA7E1A-9802-4491-B5B3-665010B4A528Q33997963-4A9EFF7F-428B-49D0-A533-9D87275BE9B9Q34133852-F9B3853D-0E97-457B-9302-4EBD2D5D0AFDQ34146164-509CA5E4-9B5C-4776-9A21-65CA52F9C6E9Q34203358-3B294CDD-507F-4AF9-8BA5-32FE22067C5BQ34349093-35B0C448-DBFA-4E0E-B5D6-2FF8D4E96A5DQ34373858-30DCF8F6-3C60-455F-83AE-774136DD0983Q34730815-085BA8B8-99C8-4411-9870-86DE0C04DEA4Q34758389-FDD0350C-F056-49C5-A73E-CFD91838EEEAQ34974953-81EF7877-BF3D-41D0-A804-F670C8BBB6AEQ35007253-41FF0A29-AF6E-44E0-9316-2708C74EB980Q35064519-8A70D992-E8D5-4BAC-8C69-D104A52CC864Q35238369-FBDC95CB-C877-4321-910C-C37E7E0091A3Q35302241-DF365969-18E7-4D14-AFDD-5158F5568BFBQ35592465-6C9BDEF5-3E90-4EFC-BA60-819B26CDB139Q35754375-E429948C-8D75-43DF-87B7-60551555F7AEQ35761771-8A5760BD-0103-44FB-A989-515E3B77D025Q35925701-16C3AC80-39F2-461C-BEA6-646991CFF76EQ35977390-F0278D35-9000-486E-A650-E6A1A8B92EE5Q36056673-ABC90988-C63F-4C2C-98CB-6E313CBDC73EQ36078738-C5E9A083-2900-46B5-A6A3-59FBB1CAAEB3
P2860
HDL and arteriosclerosis: beyond reverse cholesterol transport.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
HDL and arteriosclerosis: beyond reverse cholesterol transport.
@ast
HDL and arteriosclerosis: beyond reverse cholesterol transport.
@en
HDL and arteriosclerosis: beyond reverse cholesterol transport.
@nl
type
label
HDL and arteriosclerosis: beyond reverse cholesterol transport.
@ast
HDL and arteriosclerosis: beyond reverse cholesterol transport.
@en
HDL and arteriosclerosis: beyond reverse cholesterol transport.
@nl
prefLabel
HDL and arteriosclerosis: beyond reverse cholesterol transport.
@ast
HDL and arteriosclerosis: beyond reverse cholesterol transport.
@en
HDL and arteriosclerosis: beyond reverse cholesterol transport.
@nl
P2093
P1433
P1476
HDL and arteriosclerosis: beyond reverse cholesterol transport.
@en
P2093
Beate Kehrel
Bodo Levkau
Gerd Assmann
Jerzy-Roch Nofer
Manfred Fobker
P356
10.1016/S0021-9150(01)00651-7
P577
2002-03-01T00:00:00Z